Abstract
Myasthenia gravis and multiple sclerosis are both autoimmune diseases that affect the neuromuscular system. Patients affected by these two diseases are frequently women younger than 40 years old. Multiple sclerosis has a relapsing and remitting course, but both diseases course with progressive deterioration. Their effect on fertility has to do more with their effect on self-esteem, sexuality, and the therapies these patients require. This chapter reviews the physiopathology of these diseases, the effect of their treatments, and effect on fertility.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Myasthenia Gravis (MG)
Sussman J, Farrugia ME, Maddison P, Hill M, Leite MI, Hilton-Jones D. Myasthenia gravis: association of British Neurologists’ management guidelines. Practical neurology. 2015;15(3):199–206.
Binks S, Vincent A, Palace J. Myasthenia gravis: a clinical-immunological update. J Neurol. 2016;263(4):826–34.
Norwood F, Dhanjal M, Hill M, James N, Jungbluth H, Kyle P, et al. Myasthenia in pregnancy: best practice guidelines from a U.K. multispecialty working group. J Neurol Neurosurg Psychiatry. 2014;85(5):538–43.
Hurst RL, Gooch CL. Muscle-Specific Receptor Tyrosine Kinase (MuSK) Myasthenia Gravis. Curr Neurol Neurosci Rep. 2016;16(7):61.
Wen JC, Liu TC, Chen YH, Chen SF, Lin HC, Tsai WC. No increased risk of adverse pregnancy outcomes for women with myasthenia gravis: a nationwide population-based study. Eur J Neurol. 2009;16(8):889–94.
Multiple Sclerosis
Amato MP, Portaccio E. Fertility, pregnancy and childbirth in patients with multiple sclerosis: impact of disease-modifying drugs. CNS Drugs. 2015;29(3):207–20.
Compston A, Coles A. Multiple sclerosis. Lancet (London, England). 2008;372(9648):1502–17.
Niedziela N, Adamczyk-Sowa M, Pierzchala K. Epidemiology and clinical record of multiple sclerosis in selected countries: a systematic review. Int J Neurosci. 2014;124(5):322–30.
Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology. 1996;46(4):907–11.
Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sorensen PS, Thompson AJ, et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 2014;83(3):278–86.
Rieckmann P, Toyka KV, Bassetti C, Beer K, Beer S, Buettner U, et al. Escalating immunotherapy of multiple sclerosis--new aspects and practical application. J Neurol. 2004;251(11):1329–39.
Sorensen PS. New management algorithms in multiple sclerosis. Curr Opin Neurol. 2014;27(3):246–59.
Orton SM, Herrera BM, Yee IM, Valdar W, Ramagopalan SV, Sadovnick AD, et al. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol. 2006;5(11):932–6.
Sellner J, Kraus J, Awad A, Milo R, Hemmer B, Stuve O. The increasing incidence and prevalence of female multiple sclerosis--a critical analysis of potential environmental factors. Autoimmun Rev. 2011;10(8):495–502.
Chao MJ, Ramagopalan SV, Herrera BM, Orton SM, Handunnetthi L, Lincoln MR, et al. MHC transmission: insights into gender bias in MS susceptibility. Neurology. 2011;76(3):242–6.
Marrie RA, Cutter G, Tyry T, Hadjimichael O, Campagnolo D, Vollmer T. Changes in the ascertainment of multiple sclerosis. Neurology. 2005;65(7):1066–70.
Cavalla P, Rovei V, Masera S, Vercellino M, Massobrio M, Mutani R, et al. Fertility in patients with multiple sclerosis: current knowledge and future perspectives. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol. 2006;27(4):231–9.
Nortvedt MW, Riise T, Myhr KM, Landtblom AM, Bakke A, Nyland HI. Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction. Mult Scler (Houndmills, Basingstoke, England). 2001;7(4):231–5.
Borello-France D, Leng W, O'Leary M, Xavier M, Erickson J, Chancellor MB, et al. Bladder and sexual function among women with multiple sclerosis. Mult Scler (Houndmills, Basingstoke, England). 2004;10(4):455–61.
Zorzon M, Zivadinov R, Bosco A, Bragadin LM, Moretti R, Bonfigli L, et al. Sexual dysfunction in multiple sclerosis: a case-control study. I. Frequency and comparison of groups. Mult Scler (Houndmills, Basingstoke, England). 1999;5(6):418–27.
Hellwig K, Correale J. Artificial reproductive techniques in multiple sclerosis. Clin Immunol. 2013;149(2):219–24.
Hellwig K, Schimrigk S, Beste C, Muller T, Gold R. Increase in relapse rate during assisted reproduction technique in patients with multiple sclerosis. Eur Neurol. 2009;61(2):65–8.
Sandberg-Wollheim M, Frank D, Goodwin TM, Giesser B, Lopez-Bresnahan M, Stam-Moraga M, et al. Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis. Neurology. 2005;65(6):802–6.
Lu E, Zhu F, Zhao Y, van der Kop M, Sadovnick AD, Synnes A, et al. Birth outcomes of pregnancies fathered by men with multiple sclerosis. Mult scler (Houndmills, Basingstoke, England). 2014;20(9):1260–4.
Cocco E, Sardu C, Gallo P, Capra R, Amato MP, Trojano M, et al. Frequency and risk factors of mitoxantrone-induced amenorrhea in multiple sclerosis: the FEMIMS study. Mult Scler (Houndmills, Basingstoke, England). 2008;14(9):1225–33.
Meistrich ML, Wilson G, Mathur K, Fuller LM, Rodriguez MA, McLaughlin P, et al. Rapid recovery of spermatogenesis after mitoxantrone, vincristine, vinblastine, and prednisone chemotherapy for Hodgkin's disease. J Clin Oncol Off J Am Soc Clin Oncol. 1997;15(12):3488–95.
Awad A, Stuve O. Cyclophosphamide in multiple sclerosis: scientific rationale, history and novel treatment paradigms. Ther Adv Neurol Disord. 2009;2(6):50–61.
Watson AR, Rance CP, Bain J. Long term effects of cyclophosphamide on testicular function. Br Med J (Clin Res Ed). 1985;291(6507):1457–60.
Vukusic S, Marignier R. Multiple sclerosis and pregnancy in the treatment era. Nat Rev Neurol. 2015;11(5):280–9.
McCombe PA, Stenager E. Female infertility and multiple sclerosis: is this an issue? Multiple sclerosis (Houndmills, Basingstoke, England). 2015;21(1):5–7.
Voskuhl RR, Gold SM. Sex-related factors in multiple sclerosis susceptibility and progression. Nat Rev Neurol. 2012;8(5):255–63.
Grinsted L, Heltberg A, Hagen C, Djursing H. Serum sex hormone and gonadotropin concentrations in premenopausal women with multiple sclerosis. J Intern Med. 1989;226(4):241–4.
Marrie RA, Yu BN, Leung S, Elliott L, Warren S, Wolfson C, et al. The incidence and prevalence of thyroid disease do not differ in the multiple sclerosis and general populations: a validation study using administrative data. Neuroepidemiology. 2012;39(2):135–42.
Gnoth C, Godehardt E, Frank-Herrmann P, Friol K, Tigges J, Freundl G. Definition and prevalence of subfertility and infertility. Hum Reprod (Oxford, England). 2005;20(5):1144–7.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Goetsch, A.L., Kimelman, D., Woodruff, T.K. (2017). Autoimmune Diseases: Myasthenia Gravis and Multiple Sclerosis. In: Fertility Preservation and Restoration for Patients with Complex Medical Conditions. Springer, Cham. https://doi.org/10.1007/978-3-319-52316-3_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-52316-3_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-52315-6
Online ISBN: 978-3-319-52316-3
eBook Packages: MedicineMedicine (R0)